Yaz, Yasmin and other newer birth control pills will soon be bearing warning labels that detail the potential risk of blood clot risks, the U.S. Food and Drug Administration (FDA) announced on Tuesday ...
The most commonly used and prescribed birth control pill in the U.S. was classified by the International Agency for Research on Cancer (IARC) at the World Health Organization (WHO) as carcinogenic. In ...
No rest for the Food and Drug Administration (FDA) this week. In addition to considering broadened access to the emergency contraceptive Plan B, an FDA panel decided on Thursday to update labeling on ...
About two years after the US Food and Drug Administration approved the first over-the-counter birth control pill in the United States, a new study suggests that many people who may not have had access ...
Watson, Bayer in patent lawsuit over Yaz Yaz had U.S. sales of $173 mln for year ended Sept. 30 Nov 29 (Reuters) - Watson Pharmaceuticals Inc said it received U.S. regulatory approval for a generic ...
As social media and wellness podcasters bombard young women with messages about the pill, many are questioning what they’ve long been told. As social media and wellness podcasters bombard young women ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback